Published July 19, 2022
| Version v1
Patent
Open
C-CBL mutations and uses thereof
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
The present invention relates generally to the fields of molecular biology and growth factor regulation. The invention concerns methods and compositions useful for diagnosing and treating human lung cancer associated with mutated c-CBL.
Files
US11390922.pdf
Files
(3.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:c06e3c47d24d1dd760819c71280998d7
|
3.4 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 11390922 B2
- Patent application number
- US 201815990301 A
- Other
- oai:uchicago.tind.io:6718
Dates
- Patent filed
-
2018-05-25